M Goerig, A J Habenicht, W Zeh, P Salbach, B Kommerell, D E Rothe, W Nastainczyk, J A Glomset
Index: J. Biol. Chem. 263(36) , 19384-91, (1988)
Full Text: HTML
We used Swiss 3T3 fibroblasts stimulated with platelet-derived growth factor and HL-60 cells induced to differentiate into macrophages or neutrophils to study the regulation of prostaglandin and leukotriene synthesis. Addition of platelet-derived growth factor to quiescent 3T3 fibroblasts led within 4 h to a dramatic and preferential increase in prostacyclin synthesis from endoperoxide prostaglandin H2, and microsomal assays showed a strong platelet-derived growth factor-dependent increase in the maximal velocities (Vmax) of both prostaglandin H synthase and prostacyclin synthase. In contrast, addition of phorbol ester to HL-60 cells to induce differentiation into macrophages led within 4 h to a strong and preferential increase in thromboxane synthesis from prostaglandin H2, and microsomal assays disclosed a major rise in Vmax for both prostaglandin H synthase and thromboxane synthase. No comparable changes occurred in HL-60 cells that were differentiating into neutrophils, though upregulation of 5-lipoxygenase pathway enzymes occurred in both differentiation systems. Actinomycin D and cycloheximide prevented the appearance of all of these enzymes of eicosanoid synthesis in all three model systems. Thus, the distinctive patterns of eicosanoid synthesis that are seen in replicating fibroblasts and in differentiating macrophages and neutrophils appear to depend on a coordinate, selective upregulation of several enzymes of eicosanoid biosynthesis that is specific for each cell system.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Prostaglandin H2
CAS:42935-17-1 |
C20H32O5 |
What we know about primary dysmenorrhea today: a critical re...
2015-01-01 [Hum. Reprod. Update 21 , 762-78, (2015)] |
Anti-peptide antibodies against the human blood platelet thr...
1993-05-25 [Biochem. Pharmacol. 45(10) , 2071-8, (1993)] |
Prostaglandin endoperoxides and thromboxane A2 activate the ...
2002-01-01 [Thromb. Haemost. 87(1) , 114-21, (2002)] |
Levuglandins and isolevuglandins: stealthy toxins of oxidati...
2005-01-01 [Antioxid. Redox Signal. 7(1-2) , 185-201, (2005)] |
Pathophysiological role of thromboxane A2 and pharmacologica...
1990-01-01 [Z. Kardiol. 79 Suppl 3 , 151-4, (1990)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved